Hinge Health Inc. (NYSE:HNGE - Get Free Report) Chairman Gabriel M.I. Mecklenburg sold 33,333 shares of the business's stock in a transaction that occurred on Tuesday, April 21st. The shares were sold at an average price of $45.05, for a total value of $1,501,651.65. Following the completion of the sale, the chairman owned 33,333 shares of the company's stock, valued at approximately $1,501,651.65. This trade represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Gabriel M.I. Mecklenburg also recently made the following trade(s):
- On Wednesday, April 1st, Gabriel M.I. Mecklenburg sold 50,000 shares of Hinge Health stock. The shares were sold at an average price of $38.46, for a total value of $1,923,000.00.
- On Friday, March 6th, Gabriel M.I. Mecklenburg sold 166,666 shares of Hinge Health stock. The shares were sold at an average price of $45.32, for a total value of $7,553,303.12.
Hinge Health Trading Down 0.1%
Shares of HNGE stock opened at $44.53 on Thursday. The stock has a market cap of $3.51 billion and a P/E ratio of -3.48. The stock has a 50 day simple moving average of $41.50 and a 200 day simple moving average of $44.28. Hinge Health Inc. has a 1 year low of $30.08 and a 1 year high of $62.18.
Hinge Health (NYSE:HNGE - Get Free Report) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.45. The company had revenue of $170.73 million during the quarter, compared to the consensus estimate of $157.31 million. The company's quarterly revenue was up 45.5% compared to the same quarter last year. Analysts forecast that Hinge Health Inc. will post 0.78 EPS for the current year.
Institutional Investors Weigh In On Hinge Health
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Janney Montgomery Scott LLC lifted its stake in Hinge Health by 3.3% during the first quarter. Janney Montgomery Scott LLC now owns 9,400 shares of the company's stock worth $362,000 after purchasing an additional 300 shares during the last quarter. 1492 Capital Management LLC bought a new stake in Hinge Health during the first quarter worth $1,333,000. Cannon Global Investment Management LLC bought a new stake in Hinge Health during the first quarter worth $613,000. OP Asset Management Ltd bought a new stake in Hinge Health during the first quarter worth $852,000. Finally, CENTRAL TRUST Co bought a new stake in Hinge Health during the first quarter worth $37,000.
Wall Street Analyst Weigh In
HNGE has been the subject of several recent research reports. Piper Sandler cut their price target on Hinge Health from $71.00 to $60.00 and set an "overweight" rating for the company in a research note on Friday, January 9th. Canaccord Genuity Group cut their price target on Hinge Health from $65.00 to $53.00 and set a "buy" rating for the company in a research note on Wednesday, February 11th. Barclays cut their target price on Hinge Health from $60.00 to $52.00 and set an "overweight" rating for the company in a research note on Wednesday, February 11th. Wells Fargo & Company assumed coverage on Hinge Health in a research note on Thursday, January 8th. They set an "overweight" rating and a $68.00 target price for the company. Finally, Wall Street Zen upgraded Hinge Health from a "hold" rating to a "buy" rating in a research note on Saturday, March 7th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $56.73.
View Our Latest Report on Hinge Health
Hinge Health Company Profile
(
Get Free Report)
Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.
Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
